Qingyu Shen

1.8k citations
35 papers · 1.4k indexed · h-index 20
Topics
MicroRNA in disease regulation (11 papers)Histone Deacetylase Inhibitors Research (10 papers)Circular RNAs in diseases (5 papers)
Partner nations
South KoreaChinaGermany

In The Last Decade

Qingyu Shen

35 papers receiving 1.4k citations

Peers

Qingyu Shen
Comparison fields: 5 of 86
  • Molecular Biology 1.0k
  • Cancer Research 644
  • Epidemiology 224
  • Oncology 204
  • Geriatrics and Gerontology 153
Replace Panagiotis Sarantis with:
Panagiotis Sarantis Greece
Balachandar Venkatesan United States
Stina Garvin Sweden
Shuguang Zhu China
Yijun Shu China
Dakai Xiao China
Ming Bai China
Jiasheng Mu China
Yuyu Yang China
Maria Simonsson Sweden
Qingyu Shen relative to Panagiotis Sarantis Greece Panagiotis Sarantis's profile →
Citations per field
00.5×50×100×151×
Panagiotis Sarantis · 1×
Citations per year

Countries citing papers authored by Qingyu Shen

Since Specialization
Citations

This map shows the geographic impact of Qingyu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Shen more than expected).

Fields of papers citing papers by Qingyu Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Shen. The network helps show where Qingyu Shen may publish in the future.

Co-authorship network of co-authors of Qingyu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Shen. A scholar is included among the top collaborators of Qingyu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Shen. Qingyu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 22
4 5
5 16
6 30
7 89
8 22
9 23
10 4
11 96
12 2
13 122
14 33
15 47
16 57
17 24
18 279
19 11
20 74

About Qingyu Shen

Qingyu Shen is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Histone Deacetylase Inhibitors Research (10 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (644 citations), Geriatrics and Gerontology (153 citations) and Molecular Biology (1.0k citations). Qingyu Shen has collaborated with scholars based in South Korea, China and Germany. Frequent co-authors include Suk Woo Nam, Jung Woo Eun, Won Sang Park, Hyun Jin Bae, Hyung Seok Kim, Young Gyoon Chang, Jung Young Lee, Kwang Hwa Jung, Ji Heon Noh and Jeong Kyu Kim. Their work appears in journals such as Environmental Science & Technology, Hepatology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026